TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 3,234,000 | 1,680,804 | 1,245,572 |
Financial expenses | 119,000 | 10,747 | 13,514 |
Earnings before taxes | 537,000 | 459,969 | 366,191 |
EBITDA | 1,050,000 | 507,956 | |
Total assets | 20,551,000 | 19,428,796 | 2,305,089 |
Current assets | 1,573,000 | 1,406,601 | 1,414,442 |
Current liabilities | 621,000 | 954,326 | 177,013 |
Equity capital | 16,736,000 | 15,322,175 | 2,012,570 |
- share capital | 28,000 | 27,631 | 22,144 |
Employees (average) | 1,117 | 478 | 405 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 81.4% | 78.9% | 87.3% |
Turnover per employee | 2,895 | 3,516 | 3,075 |
Profit as a percentage of turnover | 16.6% | 27.4% | 29.4% |
Return on assets (ROA) | 3.2% | 2.4% | 16.5% |
Current ratio | 253.3% | 147.4% | 799.1% |
Return on equity (ROE) | 3.2% | 3.0% | 18.2% |
Change turnover | 1,553,196 | 435,232 | -234,560 |
Change turnover % | 92% | 35% | -16% |
Chg. No. of employees | 639 | 73 | 7 |
Chg. No. of employees % | 134% | 18% | 2% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.